Related Experiment Video
Updated: Jun 24, 2026
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART
Razieh Dehghani Firouzabadi1, Shahnaz Ahmadi, Homa Oskouian
1Fellowship of Infertility, Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Science, Yazd, Iran. dr_firouzabadi@yahoo.com
Purpose:
This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART).
Methods:
We randomized 235 patients undergoing ART for the first time. The first group was stimulated with a standard long protocol and the second group stimulated with GnRH antagonis.
Results:
There was no statistically significant difference in the age, infertility cause, basal FSH, BMI, the number of oocytes retrieved, number of M2 oocytes, embryo obtained and endometrial thickness between the two groups. But Serum estradiol, consumption of gonadotropins and ovarian hyperstimulation syndrome were significantly lower in the antagonist protocol. Cancellation rate of embryo transfer due to poor-quality embryo in the antagonist protocol was higher, but it was not significant. There was no significant difference in the clinical pregnancy and ongoing pregnancy between the two groups.
Conclusion:
GnRH-antagonist is an effective, safe, and well-tolerated alternative to agonist in the first cycle of ART.
